Welcome to our dedicated page for Global Pmts news (Ticker: GPN), a resource for investors and traders seeking the latest updates and insights on Global Pmts stock.
Global Payments reports developments in merchant payment technology, software and commerce enablement for businesses across online, in-store and platform channels. Company updates commonly cover enterprise and embedded-payment partnerships, including Genius point-of-sale deployments, Payrix Pro integrations and Link2Gov digital payment services for tax payments.
Recurring announcements also include Worldpay payment-market research, operating results, conference presentations, board and governance changes, and capital actions such as share repurchase programs. The company’s completed Worldpay acquisition and Issuer Solutions divestiture frame its current identity as a merchant-solutions business.
AdvancedMD, a Global Payments company, has announced over 30 new features in its 2024 summer product release. Key updates include the AdvancedMD Pay credit card processing system and terminal, which unifies patient billing processes. The terminal integrates with the AdvancedMD Pay platform, enabling in-person and online credit card payments, and will initially be available by invitation. Other updates include automated payment plans, insurance virtual credit card (VCC) payments, and enhanced practice management, EHR, and patient engagement tools. These updates aim to improve efficiency, productivity, and revenue for private medical practices.
Global Payments Inc. (NYSE: GPN) will have its CEO, Cameron Bready, present at the J.P. Morgan Global Technology, Media and Communications Conference on May 21, 2024. The live webcast can be accessed on the company's investor relations website.
Global Payments Inc. (NYSE: GPN) reported strong first-quarter 2024 results, with GAAP revenue reaching $2.42 billion, an increase of 6%, and adjusted net revenue hitting $2.18 billion, a 7% increase. The company reaffirmed its 2024 outlook, with a positive growth trajectory. The earnings per share (EPS) saw significant growth, with GAAP diluted EPS at $1.22 and adjusted EPS at $2.59. The company received EU regulatory approval for the Commerzbank joint venture, indicating progress in strategic partnerships.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.